SPINEWAY (ALSPW.PA) Fundamental Analysis & Valuation

EPA:ALSPW • FR001400N2P2

Current stock price

0.1608 EUR
0 (-0.74%)
Last:

This ALSPW.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ALSPW.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALSPW has reported negative net income.
  • ALSPW had a positive operating cash flow in the past year.
  • In the past 5 years ALSPW always reported negative net income.
  • In the past 5 years ALSPW reported 4 times negative operating cash flow.
ALSPW.PA Yearly Net Income VS EBIT VS OCF VS FCFALSPW.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5M -10M

1.2 Ratios

  • With a Return On Assets value of -7.60%, ALSPW is not doing good in the industry: 65.52% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of -9.71%, ALSPW is doing worse than 65.52% of the companies in the same industry.
Industry RankSector Rank
ROA -7.6%
ROE -9.71%
ROIC N/A
ROA(3y)-15.02%
ROA(5y)-12.51%
ROE(3y)-19.94%
ROE(5y)-16.33%
ROIC(3y)N/A
ROIC(5y)N/A
ALSPW.PA Yearly ROA, ROE, ROICALSPW.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400

1.3 Margins

  • ALSPW has a better Gross Margin (72.48%) than 86.21% of its industry peers.
  • ALSPW's Gross Margin has improved in the last couple of years.
  • ALSPW does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.46%
GM growth 5Y26.5%
ALSPW.PA Yearly Profit, Operating, Gross MarginsALSPW.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ALSPW.PA Health Analysis

2.1 Basic Checks

  • ALSPW does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ALSPW has more shares outstanding
  • The number of shares outstanding for ALSPW has been increased compared to 5 years ago.
  • The debt/assets ratio for ALSPW has been reduced compared to a year ago.
ALSPW.PA Yearly Shares OutstandingALSPW.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
ALSPW.PA Yearly Total Debt VS Total AssetsALSPW.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

  • ALSPW has an Altman-Z score of 1.22. This is a bad value and indicates that ALSPW is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.22, ALSPW is doing worse than 72.41% of the companies in the same industry.
  • ALSPW has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
  • With an excellent Debt to Equity ratio value of 0.07, ALSPW belongs to the best of the industry, outperforming 87.93% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z 1.22
ROIC/WACCN/A
WACC7.05%
ALSPW.PA Yearly LT Debt VS Equity VS FCFALSPW.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

2.3 Liquidity

  • A Current Ratio of 2.88 indicates that ALSPW has no problem at all paying its short term obligations.
  • The Current ratio of ALSPW (2.88) is better than 75.86% of its industry peers.
  • A Quick Ratio of 1.80 indicates that ALSPW should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.80, ALSPW is doing good in the industry, outperforming 75.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.88
Quick Ratio 1.8
ALSPW.PA Yearly Current Assets VS Current LiabilitesALSPW.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ALSPW.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 93.61% over the past year.
  • The Revenue has been growing slightly by 4.02% in the past year.
  • ALSPW shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.76% yearly.
EPS 1Y (TTM)93.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-159.55%
Revenue 1Y (TTM)4.02%
Revenue growth 3Y18.7%
Revenue growth 5Y29.76%
Sales Q2Q%26.63%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.50% on average over the next years. This is quite good.
  • Based on estimates for the next years, ALSPW will show a quite strong growth in Revenue. The Revenue will grow by 8.71% on average per year.
EPS Next Y0%
EPS Next 2Y14.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year39.63%
Revenue Next 2Y8.71%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALSPW.PA Yearly Revenue VS EstimatesALSPW.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M
ALSPW.PA Yearly EPS VS EstimatesALSPW.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 2027 0 -5M -10M -15M -20M

More info and screens

Find the best growth stocksShow best growing peers

0

4. ALSPW.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALSPW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALSPW. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALSPW.PA Price Earnings VS Forward Price EarningsALSPW.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALSPW.PA Per share dataALSPW.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALSPW's earnings are expected to grow with 14.50% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.5%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALSPW.PA Dividend Analysis

5.1 Amount

  • No dividends for ALSPW!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALSPW.PA Fundamentals: All Metrics, Ratios and Statistics

SPINEWAY

EPA:ALSPW (4/27/2026, 7:00:00 PM)

0.1608

0 (-0.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-17
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.71M
Revenue(TTM)12.43M
Net Income(TTM)-2.24M
Analysts86.67
Price Target0.31 (92.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.46
P/FCF N/A
P/OCF 13.48
P/B 0.25
P/tB 0.42
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.01
OCFY7.42%
SpS0.35
BVpS0.65
TBVpS0.38
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -7.6%
ROE -9.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 72.48%
FCFM N/A
ROA(3y)-15.02%
ROA(5y)-12.51%
ROE(3y)-19.94%
ROE(5y)-16.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.46%
GM growth 5Y26.5%
F-Score6
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 94.98%
Cap/Sales 9.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.88
Quick Ratio 1.8
Altman-Z 1.22
F-Score6
WACC7.05%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-159.55%
EPS Next Y0%
EPS Next 2Y14.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.02%
Revenue growth 3Y18.7%
Revenue growth 5Y29.76%
Sales Q2Q%26.63%
Revenue Next Year39.63%
Revenue Next 2Y8.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-586.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year113.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y82.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y112.95%
OCF growth 3YN/A
OCF growth 5YN/A

SPINEWAY / ALSPW.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SPINEWAY?

ChartMill assigns a fundamental rating of 3 / 10 to ALSPW.PA.


Can you provide the valuation status for SPINEWAY?

ChartMill assigns a valuation rating of 0 / 10 to SPINEWAY (ALSPW.PA). This can be considered as Overvalued.


How profitable is SPINEWAY (ALSPW.PA) stock?

SPINEWAY (ALSPW.PA) has a profitability rating of 2 / 10.


How financially healthy is SPINEWAY?

The financial health rating of SPINEWAY (ALSPW.PA) is 4 / 10.


How sustainable is the dividend of SPINEWAY (ALSPW.PA) stock?

The dividend rating of SPINEWAY (ALSPW.PA) is 0 / 10 and the dividend payout ratio is 0%.